Vimta Labs Ltd.

VIMTALABS

₹1153.0

10.0% (104.8)

Market Cap

₹2,331 Cr.

P/E

37.98

About

Vimta Labs Limited, established in 1984, provides analytical, clinical, preclinical services to life sciences industries, quality testing for food and beverage sectors, and environment services to var… Read more

Vimta Labs Limited, established in 1984, provides analytical, clinical, preclinical services t… Read more

Low

420

52W Range

High

1178

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

10 Yes

Positive for this company

1 Neutral

Neutral for this company

6 No

Negative for this company

0 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Revenue Recognition

Company is converting accounting profit to cash
Retail Holding

Retail has been buying the stock which is usually a sign of exuberance
Promoter Holding

Promoters has been selling shares in the open market over last 90 days

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Share price

Share price has increased over last 10 years due to earnings
Working Capital

Working capital of the company seems to be under control
Debt

Company should not have issues servicing its debt
Sales Growth

Sales of the company has grown at a good pace
Balance Sheet Strength

Balance sheet of the company is strong. but it might have issues paying it suppliers
Capex vs ROCE

Roce of the company has decreased even without significant capex
Current vs Historic Valuation

Company is trading at a premium to 3yr historic valuations
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Operational Metrics

R&D as a % of Total Sales (%)
Source

Peer Comparison

Corporate Actions

Consolidated

DATE

DETAILS

Show Less

FAQs on Vimta Labs Ltd. Business

What does Vimta Labs do?

Founded in 1984, Vimta Labs Limited provides analytical, clinical, and preclinical services to life sciences industries, quality testing for food and beverage sectors, and environmental services globally.

Who are the competitors of Vimta Labs?

Vimta Labs major competitors are Krsnaa Diagnostics, Thyrocare Tech., Nidan Labs. & Health, Metropolis Health., Vijaya Diagnostic, Dr. Lal Pathlabs, Cupid.
Market Cap of Vimta Labs is ₹2,331 Crs.
While the median market cap of its peers are ₹4,074 Crs.

Is Vimta Labs financially stable compared to its competitors?

Vimta Labs seems to be less financially stable compared to its competitors.
Altman Z score of Vimta Labs is 21.79 and is ranked 5 out of its 8 competitors.

View FAQ's On Shareprice

Cash Flow Machines

Actual Cash profits are more important than accounting profits. List of companies spitting out cash profits

Run Query

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release		Mar Jun Sep Dec	Mar Jun Sep Dec
Investor Presentation		Mar Jun Sep Dec	Mar Jun Sep Dec
Conference Call		Mar Jun Sep	Mar Jun Sep Dec	Mar Sep Dec	Mar Sep	Mar Sep Dec	Sep Dec
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Vimta Labs Ltd.

View the discussion on ValuePickr

Vimta Labs Ltd – Bet on the emerging theme of Contract Research & Testing Outsourcing - SOC Invest

Diagnostics

How The Diagnostics Industry Works - PPFAS

Diagnostic Industry - P2P Analysis - SOIC

Impact on compeitition like TATA1MG on Diagnostics Sector - Aditya Khemka(Incred) - Bloomberg Quint

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Vimta Labs Ltd.